Analysts have set price targets and positive earnings estimate revisions for Collegium Pharmaceutical (Q104480182) based on company expectations.
3 reports, 2 independent
Updated Jul 5
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts have set price targets and positive earnings estimate revisions for Collegium Pharmaceutical (Q104480182) based on company expectations.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Collegium Pharmaceutical (United States)
company in Dedham, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- ZacksWall Street Analysts See a 33.91% Upside in Collegium Pharmaceutical (COLL): Can the Stock Really Move This High? Collegium Pharmaceutical (COLL) closed the last trading session at $32.11, gaining 7.